Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Discovery Content

Bringing you the latest research in Drug Discovery In New Modalities, Integration Of DEL, Covalent Inhibitors, Protein Degradation Technologies, Computational Drug Design & Automation Strategies and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Industry Spotlight
What is AlphaFold?
AlphaFold is the protein folding solution that took computational biology by storm, but has the protein folding problem been well and truly solved?
Edited by Tom Cohen |
11 July 2023
Computational Drug Design & AI
Industry Spotlight
Lantern Pharma Offers AI Platform for ADC Discovery with Bielefeld University
Lantern will use their artificial intelligence (AI) platform, RADR, to accelerate the development of ADC candidates from discovery to clinical trials within a timeframe of approximately two years.
Edited by Tom Cohen |
12 June 2023
Computational Drug Design & AI
Industry Spotlight
University of Sydney Enters New Drug Discovery AI Partnership with Pharos Tx
The collaboration involves granting the university access to Pharos' proprietary AI platform, Chemiverse, while Pharos will collaborate with the university's drug discovery researchers and infrastructure.
Edited by Tom Cohen |
05 June 2023
Computational Drug Design & AI
Video Content
Video Q&A
Interview with Thierry Dorval, Head of Data Sciences & Data Management at Servier
Thierry Dorval from Servier talks about AI methods, their limitations, and how they are changing the way that data is viewed in the pharmaceutical industry.
Edited by Tom Cohen |
21 April 2023
Computational Drug Design & AI
Video Content
Video Q&A
Interview with Jissy Akkarapattiakal Kuriappan, Principal Investigator, Drug Discovery at Alembic Pharmaceuticals
Jissy Akkarapattiakal Kuriappan, Principal Investigator, Drug Discovery at Alembic Pharmaceuticals, discusses using AI to promote drug discovery, the problem with using AI as a black box, and whether AI and ML are a worthwhile investment.
Edited by Tom Cohen |
18 April 2023
Computational Drug Design & AI
Industry Spotlight
Oracle’s Cerner Enviza and FDA Collaborate on NLP-AI Drug Safety Tools
The oracle company will partner with the FDA and John Snow Labs to develop natural language processing backed up by AI to study drug safety.
Edited by Tom Cohen |
11 April 2023
Computational Drug Design & AI
Industry Spotlight
Orion Granted €10m to Build AI-Based ‘Research Ecosystem’ in Finland
A Finnish government agency has awarded the pharma company €‎10 million to invest in their research ecosystem utilising AI and data science.
Edited by Tom Cohen |
30 March 2023
Computational Drug Design & AI
Insight Article
Using Breakthrough Computational Tools for Drug Design and Discovery: AI/ML and Quantum Computing
How quantum annealers, which use quantum mechanics to solve optimisation problems by finding the lowest energy state of a system, are being used for drug discovery.
Edited by Tom Cohen |
29 March 2023
Computational Drug Design & AI
Industry Spotlight
Using ML with DEL: Philogen and Google Partner in New Study
The partnership has developed a new machine learning assisted-technique for DEL screening.
Edited by Tom Cohen |
28 March 2023
Computational Drug Design & AI
Insight Article
Leading Perspectives on Using AI Tools to Drive Drug Design
Our expert panel discuss the implementation of AI and ML tools for drug design: predictive models, computational chemistry, and AlphaFold.
Edited by Tom Cohen |
20 January 2023
Computational Drug Design & AI

Search by Keyword

Filter by Subject Area

Discovery Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.